Your browser doesn't support javascript.
Prevalence of Antibodies to SARS-CoV-2 in Italian Adults and Associated Risk Factors.
Vena, Antonio; Berruti, Marco; Adessi, Andrea; Blumetti, Pietro; Brignole, Michele; Colognato, Renato; Gaggioli, Germano; Giacobbe, Daniele Roberto; Bracci-Laudiero, Luisa; Magnasco, Laura; Signori, Alessio; Taramasso, Lucia; Varelli, Marco; Vendola, Nicoletta; Ball, Lorenzo; Robba, Chiara; Battaglini, Denise; Brunetti, Iole; Pelosi, Paolo; Bassetti, Matteo.
  • Vena A; Infectious Diseases Unit, San Martino Policlinico Hospital-IRCCS for Oncology and Neurosciences, 16132 Genoa, Italy.
  • Berruti M; Infectious Diseases Unit, San Martino Policlinico Hospital-IRCCS for Oncology and Neurosciences, 16132 Genoa, Italy.
  • Adessi A; Department of Health Sciences (DISSAL), University of Genoa, 16132 Genoa, Italy.
  • Blumetti P; Onilab Milano, 20123 Milano, Italy.
  • Brignole M; Medical Center srl, Sesto Calende, 21018 Varese, Italy.
  • Colognato R; Department of Cardiology, Arrhytmology Centre and Syncope Unit, Ospedale del Tigullio, 16033 Lavagna, Italy.
  • Gaggioli G; IRCCS Istituto Auxologico Italiano, Faint and Fall Programme, Ospedale San Luca, 20149 Milano, Italy.
  • Giacobbe DR; Medical Center srl, Sesto Calende, 21018 Varese, Italy.
  • Bracci-Laudiero L; Division of Cardiology, Ospedale Villa Scassi, 16149 Genova, Italy.
  • Magnasco L; Infectious Diseases Unit, San Martino Policlinico Hospital-IRCCS for Oncology and Neurosciences, 16132 Genoa, Italy.
  • Signori A; Institute of Translational Pharmacology, Consiglio Nazionale Delle Ricerche (CNR), 00185 Rome, Italy.
  • Taramasso L; Division of Rheumatology and Immuno-Rheumatology Research Laboratories, Bambino Gesù Children's Hospital, 00165 Rome, Italy.
  • Varelli M; Infectious Diseases Unit, San Martino Policlinico Hospital-IRCCS for Oncology and Neurosciences, 16132 Genoa, Italy.
  • Vendola N; Section of Biostatistics, Department of Health Sciences, University of Genova, 16132 Genova, Italy.
  • Ball L; Infectious Diseases Unit, San Martino Policlinico Hospital-IRCCS for Oncology and Neurosciences, 16132 Genoa, Italy.
  • Robba C; Diagnostic Institute Varelli, Clinical Analysis, 80126 Napoli, Italy.
  • Battaglini D; Division of Obstetrics and Gynecology, Sant'Andrea Hospital, 13100 Vercelli, Italy.
  • Brunetti I; Department of Surgical Sciences and Integrated Diagnostics, University of Genoa, 16132 Genoa, Italy.
  • Pelosi P; Anesthesia and Intensive Care, San Martino Policlinico Hospital, IRCCS for Oncology and Neurosciences, 16132 Genoa, Italy.
  • Bassetti M; Anesthesia and Intensive Care, San Martino Policlinico Hospital, IRCCS for Oncology and Neurosciences, 16132 Genoa, Italy.
J Clin Med ; 9(9)2020 Aug 27.
Article in English | MEDLINE | ID: covidwho-739098
ABSTRACT
We aimed to assess the prevalence of and factors associated with anti- severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) positivity in a large population of adult volunteers from five administrative departments of the Liguria and Lombardia regions. A total of 3609 individuals were included in this analysis. Participants were tested for anti-SARS-CoV-2 antibodies [Immunoglobulin G (IgG) and M (IgM) class antibodies] at three private laboratories (Istituto Diganostico Varelli, Medical Center, and Casa della Salute di Genova). Demographic data, occupational or private exposure to SARS-CoV-2-infected patients, and prior medical history consistent with SARS-CoV-2 infection were collected according to a preplanned analysis. The overall seroprevalence of anti-SARS-CoV-2 antibodies (IgG and/or IgM) was 11.0% [398/3609; confidence interval (CI) 10.0%-12.1%]. Seroprevalence was higher in female inmates than in male inmates (12.5% vs. 9.2%, respectively, p = 0.002), with the highest rate observed among adults aged >55 years (13.2%). A generalized estimating equations model showed that the main risk factors associated with SARS-CoV-2 seroprevalence were the following an occupational exposure to the virus [Odd ratio (OR) = 2.36; 95% CI 1.59-3.50, p = 0.001], being a long-term care facility resident (OR = 4.53; 95% CI 3.19-6.45, p = 0.001), and reporting previous symptoms of influenza-like illness (OR = 4.86; 95% CI 3.75-6.30, p = 0.001) or loss of sense of smell or taste (OR = 41.00; 95% CI 18.94-88.71, p = 0.001). In conclusion, we found a high prevalence (11.0%) of SARS-CoV-2 infection that is significantly associated with residing in long-term care facilities or occupational exposure to the virus. These findings warrant further investigation into SARS-CoV-2 antibody prevalence among the Italian population.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Observational study / Prognostic study Topics: Long Covid Language: English Year: 2020 Document Type: Article Affiliation country: Jcm9092780

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Observational study / Prognostic study Topics: Long Covid Language: English Year: 2020 Document Type: Article Affiliation country: Jcm9092780